» Articles » PMID: 38851875

Determining the Optimal Dosage of Dexmedetomidine for Smooth Emergence in Older Patients Undergoing Spinal Surgery: A Study of 44 Cases

Overview
Journal Med Sci Monit
Date 2024 Jun 9
PMID 38851875
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Emergence agitation, or delirium, occurs during early recovery from general anesthesia and involves disorientation, excitation, and uncontrolled physical movements. Dexmedetomidine is an alpha agonist that has sedative, anxiolytic, analgesic, and sympatholytic activities and is used as a continuous infusion to prevent emergence agitation. This study aimed to evaluate patients aged 65 years and older undergoing general anesthesia to determine the 90% effective dose (ED90) of dexmedetomidine continuous intraoperative infusion to prevent emergence agitation. MATERIAL AND METHODS We enrolled 44 patients aged 65 years and older undergoing spinal surgery under general anesthesia. Dexmedetomidine administration commenced 30 minutes before surgery completion, with a predetermined infusion dose (μg/kg/h), without a loading dose. The initial dose was 0.2 μg/kg/h, and subsequent step size was ±0.05 μg/kg/h. We tried to find ED90 of dexmedetomidine using the biased-coin design. Vital signs, extubation quality scores, extubation-related complications, and postoperative outcomes were monitored. RESULTS Dexmedetomidine ED₉₀ for smooth emergence in older patients was 0.34 μg/kg/h. Peri-extubation vital signs remained within 20% of baseline values, without requiring pharmacological intervention. No hypoxia, hypoventilation, or post-extubation agitation occurred. In the recovery room, 1 patient briefly exhibited excitement but quickly calmed. Nine patients initially unresponsive in the recovery room fully awoke and were promptly discharged. CONCLUSIONS For older patients who are vulnerable to adverse effects of anesthetics and opioids, dexmedetomidine enables gentle awakening without adverse vital sign changes, respiratory depression, excessive sedation, or emergence agitation (ED₉₀=0.34 μg/kg/h). Further studies should involve a larger patient cohort, considering diverse medical conditions in older individuals.

References
1.
Ickeringill M, Shehabi Y, Adamson H, Ruettimann U . Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy. Anaesth Intensive Care. 2005; 32(6):741-5. DOI: 10.1177/0310057X0403200602. View

2.
Leech P, Barker J, Fitch W . Proceedings: Changes in intracranial pressure and systemic arterial pressure during the termination of anaesthesia. Br J Anaesth. 1974; 46(4):315-6. DOI: 10.1093/bja/46.4.315-a. View

3.
Wang Y, Chen L, Wu B, Zhang X, Zhu C, Li Y . [Different doses of dexmedetomidine for quiet extubation during anesthesia recovery in hypertensive patients]. Zhonghua Yi Xue Za Zhi. 2016; 95(38):3129-32. View

4.
Zhou D, Yang X, Wu H, Xiong G, Wang L . Determination of the ED90 of Dexmedetomidine Infusion to Prevent Emergence Agitation in Children Undergoing Dental Rehabilitation With Sevoflurane Anesthesia: A Biased-Coin Up-and-Down Sequential Allocation Trial. Anesth Analg. 2023; 139(4):761-769. DOI: 10.1213/ANE.0000000000006626. View

5.
Nishino T, Tagaito Y, Isono S . Cough and other reflexes on irritation of airway mucosa in man. Pulm Pharmacol. 1996; 9(5-6):285-92. DOI: 10.1006/pulp.1996.0037. View